These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3095777)

  • 1. [Acute reversible agranulocytosis during ceftriaxone treatment].
    Becq-Giraudon B; Cazenave F; Breux JP
    Pathol Biol (Paris); 1986 May; 34(5):534-5. PubMed ID: 3095777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of ceftriaxone in severe infections in adults].
    Lacut JY; Dupon M; Quentin C; Brachet-Liermain A; Granger C; Echinard E
    Pathol Biol (Paris); 1986 May; 34(5):451-6. PubMed ID: 3534720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agranulocytosis and epileptic seizure during prolonged ceftriaxone treatment].
    Vandenbos F; Baldin B; Garraffo R; Mondain-Miton V; Dellamonica P
    Ann Med Interne (Paris); 2001 Apr; 152(3):215-6. PubMed ID: 11431585
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
    Plakogiannis R; Nogid A
    Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy.
    Duncan CJ; Evans TJ; Seaton RA
    J Antimicrob Chemother; 2010 Nov; 65(11):2483-4. PubMed ID: 20810422
    [No Abstract]   [Full Text] [Related]  

  • 7. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agranulocytosis from Outpatient Antimicrobial Treatment with Ceftriaxone: A Case Report.
    Genchanok Y; Tolu SS; Wang H; Arora S
    Perm J; 2019; 23():. PubMed ID: 31314727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis.
    Stone HH; Mullins RJ; Strom PR; Bourneuf AA; Geheber CE
    Am J Surg; 1984 Oct; 148(4A):30-4. PubMed ID: 6091478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone-induced agranulocytosis.
    Reichman N; Raz R; Schlaeffer F; Elias M; Flatau E
    Isr J Med Sci; 1993 Jan; 29(1):52-4. PubMed ID: 8454452
    [No Abstract]   [Full Text] [Related]  

  • 11. Tocainide-induced reversible agranulocytosis and anemia.
    Soff GA; Kadin ME
    Arch Intern Med; 1987 Mar; 147(3):598-9. PubMed ID: 3103562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.
    Khan S; Gupta DK; Khan DN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
    Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
    J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Austrian syndrome, ceftriaxone-induced agranulocytosis and COVID-19.
    McCulloch JE; Miller A; Borcea M; Reid J
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33408111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case from general practice. Agranulocytosis].
    Osterwalder P; Stocker D
    Praxis (Bern 1994); 1998 Aug; 87(33):1030-3. PubMed ID: 9747134
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-induced (probably allopurinol) agranulocytosis. Case report and discussion].
    Schär B; Meier C; Affolter H
    Schweiz Med Wochenschr; 1994 Apr; 124(13):545-9. PubMed ID: 8171306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report.
    Mobascher J; Zielasek J; Schuier FJ; Mobascher A; Grohmann R; Agelink MW; Cordes J
    Pharmacopsychiatry; 2005 Nov; 38(6):329-30. PubMed ID: 16342008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case 4/2011--agranulocytosis and puerperal sepsis in women after the use of ceftriaxone.
    Candido HM; Bortolotto MR; Strabelli TM; Benvenuti LA
    Arq Bras Cardiol; 2011 Aug; 97(2):e20-8. PubMed ID: 22002032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.